Gastrointestinal Cancer News

In a video interview with Healio, Benjamin Schlechter, MD, of Dana-Farber Cancer Institute, spoke about “the first combination to show efficacy in colorectal cancer in a specialized population.”

Bariatric surgery was associated with a decreased incidence of esophageal and gastric cancer as well as in-hospital mortality in a cohort of patients with severe obesity, according to results published in JAMA Surgery.

The FDA announced several regulatory actions the past few weeks.

Only 30% of individuals with neuroendocrine tumors rank living longer as their single top priority in treating their cancer, according to a study conducted by researchers at City of Hope.

Patient withdrawal from cancer clinical trials can result in systematic bias, insufficiently powered studies and a loss of valuable scientific knowledge, according to a study in JAMA Network Open.

High-intensity aerobic exercise may decrease the risk for cancer metastasis by 72%, according to a study conducted at Tel Aviv University.

Liquid biopsy effectively predicted survival outcomes among a cohort of patients with various metastatic cancer types, according to study results published in Annals of Oncology.

Moderate exercise may improve longevity for patients with colorectal cancer by acting on the gut microbiome, according to a study published in American Journal of Cancer Research.

Irinotecan liposome injection combined with 5-FU/leucovorin and oxaliplatin prolonged OS compared with nab-paclitaxel and gemcitabine as initial treatment for patients with metastatic pancreatic ductal adenocarcinoma, study results showed.

Single-fraction radiation therapy reduced hepatic pain among most patients with end-stage hepatocellular carcinoma or liver metastases, according to randomized phase 3 study results presented at ASCO Gastrointestinal Cancers Symposium.